William J Murphy

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Venues

Journal for immunotherapy of cancer

Nature communications

Cellular & molecular immunology

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Robert J Canter, Sean J Judge, Craig P Collins, Daniel Jaeho Yoon, William J Murphy
Suppressive effects of obesity on NK cells: is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens? Journal for immunotherapy of cancer 12 (3) (2024)
Aryana M Razmara, Lauren E Farley, Rayna M Harris, Sean J Judge, Marshall Lammers, Khurshid R Iranpur, Eric G Johnson, Cordelia Dunai, William J Murphy, C Titus Brown, Robert B Rebhun, Michael S Kent, Robert J Canter
Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer. Journal for immunotherapy of cancer 12 (4) (2024)
Aryana M Razmara, Lauren E Farley, Rayna M Harris, Sean J Judge, Marshall Lammers, Khurshid R Iranpur, Eric G Johnson, Cordelia Dunai, William J Murphy, C Titus Brown, Robert B Rebhun, Michael S Kent, Robert J Canter
Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer. Journal for immunotherapy of cancer 12 (4) (2024)
Aryana M Razmara, Lauren E Farley, Rayna M Harris, Sean J Judge, Marshall Lammers, Khurshid R Iranpur, Eric G Johnson, Cordelia Dunai, William J Murphy, C Titus Brown, Robert B Rebhun, Michael S Kent, Robert J Canter
Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer. Journal for immunotherapy of cancer 12 (4) (2024)
Robert J Canter, Sean J Judge, Craig P Collins, Daniel Jaeho Yoon, William J Murphy
Suppressive effects of obesity on NK cells: is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens? Journal for immunotherapy of cancer 12 (3) (2024)
Aryana M Razmara, Lauren E Farley, Rayna M Harris, Sean J Judge, Marshall Lammers, Khurshid R Iranpur, Eric G Johnson, Cordelia Dunai, William J Murphy, C Titus Brown, Robert B Rebhun, Michael S Kent, Robert J Canter
Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer. Journal for immunotherapy of cancer 12 (4) (2024)
Aryana M Razmara, Lauren E Farley, Rayna M Harris, Sean J Judge, Marshall Lammers, Khurshid R Iranpur, Eric G Johnson, Cordelia Dunai, William J Murphy, C Titus Brown, Robert B Rebhun, Michael S Kent, Robert J Canter
Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer. Journal for immunotherapy of cancer 12 (4) (2024)
Aryana M Razmara, Lauren E Farley, Rayna M Harris, Sean J Judge, Marshall Lammers, Khurshid R Iranpur, Eric G Johnson, Cordelia Dunai, William J Murphy, C Titus Brown, Robert B Rebhun, Michael S Kent, Robert J Canter
Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer. Journal for immunotherapy of cancer 12 (4) (2024)
Robert J Canter, Sean J Judge, Craig P Collins, Daniel Jaeho Yoon, William J Murphy
Suppressive effects of obesity on NK cells: is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens? Journal for immunotherapy of cancer 12 (3) (2024)
Robert J Canter, Sean J Judge, Craig P Collins, Daniel Jaeho Yoon, William J Murphy
Suppressive effects of obesity on NK cells: is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens? Journal for immunotherapy of cancer 12 (3) (2024)
Pengfei Xu, Joy C Yang, Bo Chen, Christopher Nip, Jonathan E Van Dyke, Xiong Zhang, Hong-Wu Chen, Christopher P Evans, William J Murphy, Chengfei Liu
Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment. Journal for immunotherapy of cancer 11 (5) (2023)
Lauren M Perry, Sylvia Margret Cruz, Kara T Kleber, Sean J Judge, Morgan A Darrow, Louis B Jones, Ugur N Basmaci, Nikhil Joshi, Matthew L Settles, Blythe P Durbin-Johnson, Alicia A Gingrich, Arta Monir Monjazeb, Janai Carr-Ascher, Steve W Thorpe, William J Murphy, Jonathan A Eisen, Robert J Canter
Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis. Journal for immunotherapy of cancer 11 (1) (2023)
Pengfei Xu, Joy C Yang, Bo Chen, Christopher Nip, Jonathan E Van Dyke, Xiong Zhang, Hong-Wu Chen, Christopher P Evans, William J Murphy, Chengfei Liu
Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment. Journal for immunotherapy of cancer 11 (5) (2023)
Lauren M Perry, Sylvia Margret Cruz, Kara T Kleber, Sean J Judge, Morgan A Darrow, Louis B Jones, Ugur N Basmaci, Nikhil Joshi, Matthew L Settles, Blythe P Durbin-Johnson, Alicia A Gingrich, Arta Monir Monjazeb, Janai Carr-Ascher, Steve W Thorpe, William J Murphy, Jonathan A Eisen, Robert J Canter
Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis. Journal for immunotherapy of cancer 11 (1) (2023)
Lauren M Perry, Sylvia Margret Cruz, Kara T Kleber, Sean J Judge, Morgan A Darrow, Louis B Jones, Ugur N Basmaci, Nikhil Joshi, Matthew L Settles, Blythe P Durbin-Johnson, Alicia A Gingrich, Arta Monir Monjazeb, Janai Carr-Ascher, Steve W Thorpe, William J Murphy, Jonathan A Eisen, Robert J Canter
Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis. Journal for immunotherapy of cancer 11 (1) (2023)
Arta M Monjazeb, Megan E Daly, Guilluame Luxardi, Emanual Maverakis, Alexander A Merleev, Alina I Marusina, Alexander D Borowsky, Amin Mirhadi, Stephen L Shiao, Laurel Beckett, Shuai Chen, David Eastham, Tianhong Li, Logan V Vick, Heather M McGee, Frances Lara, Leslie Garcia, Leigh Anne Morris, Robert J Canter, Jonathan W Riess, Kurt A Schalper, William J Murphy, Karen Kelly
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial. Nature communications 14 (1) (2023)
Lauren M Perry, Sylvia Margret Cruz, Kara T Kleber, Sean J Judge, Morgan A Darrow, Louis B Jones, Ugur N Basmaci, Nikhil Joshi, Matthew L Settles, Blythe P Durbin-Johnson, Alicia A Gingrich, Arta Monir Monjazeb, Janai Carr-Ascher, Steve W Thorpe, William J Murphy, Jonathan A Eisen, Robert J Canter
Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis. Journal for immunotherapy of cancer 11 (1) (2023)
Nicholas L Bayless, Jeffrey A Bluestone, Samantha Bucktrout, Lisa H Butterfield, Elizabeth M Jaffee, Christian A Koch, Bart O Roep, Arlene H Sharpe, William J Murphy, Alexandra-Chloé Villani, Theresa L Walunas
Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR. Journal for immunotherapy of cancer 9 (9) (2022)
Govindarajan Thangavelu, Gabriela Andrejeva, Sara Bolivar-Wagers, Sujeong Jin, Michael C Zaiken, Michael Loschi, Ethan G Aguilar, Scott N Furlan, Chrysothemis C Brown, Yu-Chi Lee, Cameron McDonald Hyman, Colby J Feser, Angela Panoskaltsis-Mortari, Keli L Hippen, Kelli P MacDonald, William J Murphy, Ivan P Maillard, Geoffrey R Hill, David H Munn, Robert Zeiser, Leslie S Kean, Jeffrey C Rathmell, Hongbo Chi, Randolph J Noelle, Bruce R Blazar
Retinoic acid signaling acts as a rheostat to balance Treg function. Cellular & molecular immunology 19 (7) (2022)
Robert B Rebhun, Daniel York, Sylvia Margret Cruz, Sean J Judge, Aryana M Razmara, Lauren E Farley, Rachel V Brady, Eric G Johnson, Jenna H Burton, Jennifer Willcox, Luke A Wittenburg, Kevin Woolard, Cordelia Dunai, Susan L Stewart, Ellen E Sparger, Sita S Withers, Alicia A Gingrich, Katherine A Skorupski, Sami Al-Nadaf, Amandine T LeJeune, William Tn Culp, William J Murphy, Michael S Kent, Robert J Canter
Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of response. Journal for immunotherapy of cancer 10 (6) (2022)
William J Murphy
Giving alloHSCT a needed LIF(t). Blood 140 (19) (2022)
Nian Jiang, Bowen Xie, Wenwu Xiao, Ming Fan, Shanxiu Xu, Yixin Duan, Yamah Hamsafar, Angela C Evans, Jie Huang, Weibing Zhou, Xuelei Lin, Ningrong Ye, Siyi Wanggou, Wen Chen, Di Jing, Ruben C Fragoso, Brittany N Dugger, Paul F Wilson, Matthew A Coleman, Shuli Xia, Xuejun Li, Lun-Quan Sun, Arta M Monjazeb, Aijun Wang, William J Murphy, Hsing-Jien Kung, Kit S Lam, Hong-Wu Chen, Jian Jian Li
Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion. Nature communications 13 (1) (2022)
Lam T Khuat, Catherine T Le, Chien-Chun Steven Pai, Robin R Shields-Cutler, Shernan G Holtan, Armin Rashidi, Sarah L Parker, Dan Knights, Jesus I Luna, Cordelia Dunai, Ziming Wang, Ian R Sturgill, Kevin M Stoffel, Alexander A Merleev, Shyam K More, Emanual Maverakis, Helen E Raybould, Mingyi Chen, Robert J Canter, Arta M Monjazeb, Maneesh Dave, James L M Ferrara, John E Levine, Dan L Longo, Mehrdad Abedi, Bruce R Blazar, William J Murphy
Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation. Science translational medicine 12 (571) (2021)
Ethan G Aguilar, Cordelia Dunai, Sean J Judge, Anthony E Zamora, Lam T Khuat, Logan V Vick, Craig P Collins, Kevin M Stoffel, Maite Alvarez, Isabel Barao, Jeffrey S Miller, Bruce R Blazar, Patrice Chevallier, Christelle Retiere, Robert J Canter, William J Murphy
Activation status dictates the function of unlicensed natural killer cells in mice and humans. Blood advances 5 (20) (2021)
Demet Candas-Green, Bowen Xie, Jie Huang, Ming Fan, Aijun Wang, Cheikh Menaa, Yanhong Zhang, Lu Zhang, Di Jing, Soheila Azghadi, Weibing Zhou, Lin Liu, Nian Jiang, Tao Li, Tianyi Gao, Colleen Sweeney, Rulong Shen, Tzu-Yin Lin, Chong-Xian Pan, Omer M Ozpiskin, Gayle Woloschak, David J Grdina, Andrew T Vaughan, Ji Ming Wang, Shuli Xia, Arta M Monjazeb, William J Murphy, Lun-Quan Sun, Hong-Wu Chen, Kit S Lam, Ralph R Weichselbaum, Jian Jian Li
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. Nature communications 11 (1) (2020)
Catherine T Le, William J Murphy
Moving forward to address key unanswered questions on targeting PD-1/PD-L1 in cancer: limitations in preclinical models and the need to incorporate human modifying factors. Journal for immunotherapy of cancer 7 (1) (2019)
Ziming Wang, Ethan G Aguilar, Jesus I Luna, Cordelia Dunai, Lam T Khuat, Catherine T Le, Annie Mirsoian, Christine M Minnar, Kevin M Stoffel, Ian R Sturgill, Steven K Grossenbacher, Sita S Withers, Robert B Rebhun, Dennis J Hartigan-O'Connor, Gema Méndez-Lagares, Alice F Tarantal, R Rivkah Isseroff, Thomas S Griffith, Kurt A Schalper, Alexander Merleev, Asim Saha, Emanual Maverakis, Karen Kelly, Raid Aljumaily, Sami Ibrahimi, Sarbajit Mukherjee, Michael Machiorlatti, Sara K Vesely, Dan L Longo, Bruce R Blazar, Robert J Canter, William J Murphy, Arta M Monjazeb
Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nature medicine 25 (1) (2018)

William J Murphy.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

William J Murphy